Top Banner
CARDIAC DISEASE PART II Nicole Weiss, MD Tulane University, December 13, 2012
39

Cardiac disease Part II

Feb 23, 2016

Download

Documents

danton

Nicole Weiss, MD Tulane University, December 13, 2012. Cardiac disease Part II. Time Crunch…. Valvular Heart Disease Hypertrophic Cardiomyopathy The Transplanted Heart Congenital Heart Disease Simple Shunts Complex Shunts Antibiotic Prophylaxis Pacemaker Classification. - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Cardiac  disease  Part  II

CARDIAC DISEASE PART IINicole Weiss, MD Tulane University, December 13, 2012

Page 2: Cardiac  disease  Part  II

Time Crunch… Valvular Heart Disease Hypertrophic Cardiomyopathy The Transplanted Heart Congenital Heart Disease

Simple Shunts Complex Shunts

Antibiotic Prophylaxis Pacemaker Classification

Page 3: Cardiac  disease  Part  II

New York Classification of Functional Heart DiseaseClass I: Asymptomatic except during Severe

ExertionClass II: Symptomatic with Moderate ActivityClass III: Symptomatic with Minimal ActivityClass IV: Symptomatic at Rest

Page 4: Cardiac  disease  Part  II

Valvular Disease

Page 5: Cardiac  disease  Part  II

Mitral Stenosis Most common etiology is rheumatic

disease Symptoms develop 20-30 years later

when mitral valve area decreases from 4-6 cm2 to less than 2cm2

Prone to Pulmonary Hypertension & Pulmonary Edema as Left Atrial Pressures Increase

Page 6: Cardiac  disease  Part  II

Anesthetic Goals for Mitral Stenosis Pulmonary Artery Catheter?

Yes, pulmonary artery pressures help guide fluid management

Patients are prone to volume overload and pulmonary edema SVR?

High, flow through the stenotic valve is limited and the heart cannot compensate for decreases in preload

Heart Rate? Normal Sinus Rhythm, Filling is dependent on atrial kick, but

too low and the cardiac output may not be sufficient Supraventricular Tachycardia may cause sudden

hemodynamic collapse

Page 7: Cardiac  disease  Part  II

Clinical Correlations Ephedrine or Phenylephrine?

Phenylephrine Ketamine?

Bad Pancuronium?

Bad Neuraxial Anesthesia?

Spinal probably not the best choice Epidurals give us time to stabilize the

hemodynamics

Page 8: Cardiac  disease  Part  II

Aortic Stenosis Critical Valve Area: 0.5-0.7 cm2 Similar management to MS Management Goals:

Normal Intravascular Volume High SVR Normal Sinus Heart Rate (60-90)

Cardiac Output does not increase with exertion

Myocardial Oxygen Demand High (Hypertrophied Ventricle)

Page 9: Cardiac  disease  Part  II

Aortic & Mitral Regurgitation Management Goals:

Fast Heart Rate (80-100) Decreased Afterload to

Promote Forward Flow

Mitral Regurgitation Pulmonary Artery Waveform: Large V Wave, Rapid Y

Descent

Page 10: Cardiac  disease  Part  II

A 70 y/o male with severe aortic stenosis has a preinduction HR of 63 and BP of 125/70. Following induction, his HR is 90 and BP is 85/45. The EKG has a new ST Elevation. Drug of Choice?1. Epinephrine2. Isoproterenol3. Calcium Chloride4. Phenylephrine5. Ephedrine

Page 11: Cardiac  disease  Part  II

Pulse Variations Bisferiens Pulse

Characteristic of Aortic Regurgitation First Systolic Peak=LV Ejection Second Systolic Peak= Reflected Pressure

Wave in the Periphery

Pulses Tardus et Parvus Characteristic of Aortic Stenosis Delayed Pulse Wave with a

Diminished Upstroke

Page 12: Cardiac  disease  Part  II

Hypertrophic Cardiomyopathy

Page 13: Cardiac  disease  Part  II

Hypertrophic Cardiomyopathy Diastolic Dysfunction Dynamic Obstruction of the LV

Outflow Tract (25% of patients) Caused by Narrowing in the

Subaortic Area by Systolic Anterior Motion (SAM) of the Anterior Mitral Valve Leaflet Against the Hypertrophied Septum

Supraventricular & Ventricular Arrhythmias

Page 14: Cardiac  disease  Part  II

Anesthetic Management Factors that Worsen Obstruction:

Enhanced Contractility Decreased Ventricular Volume Decreased LV Afterload

B-Blockers & Ca-Channel Blockers Amiodarone for Arrhythmias Ideal Anesthetic: Halothane

Decreases Myocardial Contractility Maintains SVR

Avoid: Nitrates, Digoxin, Diuretics

Page 15: Cardiac  disease  Part  II

The Transplanted

Heart

Page 16: Cardiac  disease  Part  II

The Transplanted Heart Denervated No sympathetic or parasympathetic

input Resting Heart Rate 100-120 (no

vagal) Responsive to catecholamines Low cardiac output, slow to pick up EKG shows two P waves

Page 17: Cardiac  disease  Part  II

Pharmacology Direct agents are the best:

Epinephrine & Isoproterenol Indirect vasopressors also work, but are

dependent on catecholamine stores Heart rate is NOT affected by:

Anticholinergics Pancuronium Meperidine Opiods Cholinesterase Inhibitors

Page 18: Cardiac  disease  Part  II

A patient has a heart rate of 110 after heart transplant. The most likely etiology is: 1. Altered Barorecepter Sensitivity2. Cardiac Denervation3. Compensation for a fixed Stroke

Volume4. Cyclosporine5. Prednisone

Page 19: Cardiac  disease  Part  II

Left to Right (Simple) Shunts

Page 20: Cardiac  disease  Part  II

Qp : Qs=

Ratios < 1 Right->Left

Ratios >1 Left->Right

Ratios = 1 No Shunting or Bidirectional Shunts of

Equal Magnitude

(CaO2-CvO2)/(CpvO2-CpaO2)

Page 21: Cardiac  disease  Part  II

Factors Altering Shunts SVR

Increase: Phenylephrine, Norepinephrine, Ketamine

Decrease: Propofol, Inhaled Agents (Iso, Sevo, Des),

Dexmetomidine Nitroprusside, Nitroglycerin, Nicardipine,

Milrinone, Fenoldopam, Adenosine PVR

Increase: Hypercapnea, Acidosis, Hypoxemia, Positive Pressure

Ventilation, Hypothermia, Reactions to the ETT

Page 22: Cardiac  disease  Part  II

Shunts & Induction of Anesthesia R->L Shunt

Longer Inhalation Induction Shorter IV Induction

L->R Shunt Shorter Inhalation Induction Longer IV Induction

Page 23: Cardiac  disease  Part  II

Compared with a normal patient, which of the following is true in a patient with a right->left intracardiac shunt? (More than one answer)1. Inhalation Induction is slowed2. Induction rate for halothane is

affected more than the induction rate for nitrous oxide

3. IV induction is more rapid4. Increased doses of IV agents are

required

Page 24: Cardiac  disease  Part  II

Atrial Septal Defects Ostium Secundum

Most Common Area of Fossa Ovalis Usually Isolated Defects Usually Asymptomatic

Ostium Primus & Sinus Venosus Associated with Other Cardiac Defects Large Ostium Primum can cause a Large Shunt and

Mitral Regurgitation Atrioventricular Septal Defects

Endocardial Cushion Defects Contiguous Atrial & Ventricular Defects Associated with Downs Large Shunts

Page 25: Cardiac  disease  Part  II

Ventricular Septal Defects Most common congenital defect Small VSDs often close during

childhood Restrictive are associated with small

L->R Large defects produce large L->R

shunts that vary with SVR and PVR Large VSDs are surgically repaired

before pulmonary disease and Eisenmenger develop

Page 26: Cardiac  disease  Part  II

Patent Ductus Arteriosus •Closes within 15 hrs

•Factors that Keep Open:• High Prostaglandins• Hypoxemia• Nitric Oxide

•Factors that Close• Low Prostaglandins• High Oxygen• Endothelin-1• Norepinephrine• Ach

•Left Untreated-> Eisenmenger

Page 27: Cardiac  disease  Part  II

Right to Left (Complex)

Shunts

Page 28: Cardiac  disease  Part  II

Tetralogy of Fallot1.RV Obstruction

(Infundibular Spasm)

2.RVH3.VSD4.Overriding Aorta

5.20% have Pulmonic Stenosis

Page 29: Cardiac  disease  Part  II

Management of Tetralogy Two components of Shunt (R->L)

Fixed (Obstruction of the Outflow Tract) Dynamic (PVR: SVR or Qp:Qs)

Decrease the Shunt Propranolol

Propranolol decreases infundibular spasm SVR

Keep SVR high!

Page 30: Cardiac  disease  Part  II

Tetralogy of Fallot… Four Parts?

RV Outflow Obstruction, RVH, Overriding Aorta, VSD Ketamine?

Maintains SVR Propranolol?

Decreases Infundibular Spasm Prostaglandin E1?

Keeps PDA open Augments Pulmonary Blood Flow in the case of

Right Ventricular Obstruction

Page 31: Cardiac  disease  Part  II

Tricuspid Atresia Small RV Large LV Limited Pulmonary

Blood Flow Arterial Hypoxemia

ASD: Mixes oxygenated with deoxygenated, Ejects through LV

Pulmonary Blood Flow is via a VSD, PDA, or Bronchial Vessels

Page 32: Cardiac  disease  Part  II

Fontan ProcedureAnastamosis of the Right Atrial Appendage to the Pulmonary Artery

Used to correct decreased pulmonary Artery blood flow or for patients with a single ventricle

After CPB: Maintain increased right atrial pressures to Facilitates pulmonary blood flow

Patients with a Fontan: Monitor CVP (which equals the PAP ) Follow intravascular fluid volume, pulmonary pressures and

detect LV impairment

Page 33: Cardiac  disease  Part  II

Transposition of the Great Arteries

Parallel Systems Treatment:

Prostaglandin E Balloon Atrial

Septoplasty

Decrease PVR, Increase SVR

Page 34: Cardiac  disease  Part  II

Hypoplastic Left Heart LV Hypoplasia MV Hypoplasia AV Atresia Aortic Hypoplasia

Prone to Ventricular Arrhythmias

Increased Pulmonary Blood Flow-> Systemic & Myocardial Ischemia

Delicate Balance Between PVR & SVR

Page 35: Cardiac  disease  Part  II

Truncus Arteriosus Increased Pulmonary

Blood Flow-> Myocardial Ischemia

Management: Phenylephrine & Fluids PEEP

Page 36: Cardiac  disease  Part  II

Anastamosis of the right atrium to the pulmonary arter (Fontan procedure is useful surgical treatment for each of the following except:1. Tricuspid Atresia2. Hypoplastic Left Heart Syndrome3. Pulmonary Valve Stenosis4. Truncus Arteriosus5. Pulmonary Artery Atresia

Page 37: Cardiac  disease  Part  II

Appropriate therapy for “tet spells” include (may be more than one): 1. Propranolol 2. Dobutamine 3. Phenylephrine 4. Ephedrine

Page 38: Cardiac  disease  Part  II

Antibiotic Prophylaxis High Risk:

Previous Infective Endocarditis Prosthetic Valves CHD (some) Transplants

Procedure Type None for GI/GU Bronchoscopy- depends Dental Procedures- depends

Page 39: Cardiac  disease  Part  II

Pacemaker Codes Chamber Paced

OAVD Chamber Sensed

OAVD Response to Sensing

OTID